首頁 > 市場調查報告書 > 製藥

開發平台分析

市場調查報告書

商品編碼

1741432

西尼羅河病毒 (WNV) 市場按產品類型、給藥途徑、分銷管道和地區分類

West Nile Virus Market, By Product Type, By Route of Administration, By Distribution Channel, By Region

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

西尼羅河病毒 (WNV) 市場規模預計在 2025 年為 7.42 億美元，預計到 2032 年將達到 12.799 億美元，2025 年至 2032 年的年複合成長率為 8.1%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	7.42億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年年複合成長率：	8.10%	2032年價值預測	12.799億美元

西尼羅河病毒 (WNV) 是一種由蚊子傳播的疾病，可感染人類、鳥類和其他動物。該病毒於 1937 年在烏干達西尼羅河地區首次發現，此後傳播至世界各地，包括北美、歐洲和亞洲。該病毒主要透過受感染蚊子的叮咬傳播給人類。 WNV 可引起一系列症狀，從輕微的類流感症狀到嚴重的神經系統疾病，例如腦炎和腦膜炎。大多數感染者不會出現任何症狀，但約 20% 的人可能會發燒、頭痛、身體疼痛、噁心、嘔吐和皮疹。在極少數情況下，WNV 可能致命。

市場動態：

全球西尼羅河病毒 (WNV) 市場受到多種因素驅動。西尼羅河病毒感染發生率的上升，尤其是在北美和歐洲，是市場成長的主要驅動力之一。此外，人們對該疾病及其預防和診斷的認知不斷提高也促進了市場擴張。例如，根據美國疾病管制與預防中心 (CDC) 的數據，向國家監測系統報告的西尼羅河病毒 (WNV) 神經侵入性疾病病例數從 2021 年的 2,000 多例增加到 2022 年的 2,500 多例。德克薩斯州、加州、路易斯安那州、內布拉斯加州和伊利諾州等州的病例數最多。病毒的傳播可能是由於氣候變遷引起的氣溫上升，這延長了感染季節並擴大了傳播病毒的蚊子的地理範圍。

然而，有幾個因素阻礙了市場的成長。有效治療方法和疫苗的有限性是對抗西尼羅河病毒的一大挑戰。診斷和治療的高成本也進一步阻礙了市場的成長。

儘管面臨諸多挑戰，市場參與企業仍有機會。新興經濟體的高成長潛力、有效治療方法的開發以及蚊蟲控制方法的日益普及，都提供了巨大的成長機會。此外，製藥公司與研究機構之間的合作可以加速開發針對西尼羅河病毒的創新解決方案。

本研究的主要特點

本報告對全球西尼羅河病毒 (WNV) 市場進行了詳細分析，並以 2024 年為基準年，展示了預測期 2025-2032 的市場規模和年複合成長率（CAGR%）。
它還揭示了不同領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
該報告根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，對全球西尼羅河病毒 (WNV) 市場的主要企業進行了概述。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球西尼羅河病毒 (WNV) 市場的各種策略矩陣來促進決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 742.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.10%	2032 Value Projection:	USD 1,279.9 Mn

West Nile virus (WNV) is a mosquito-borne disease that affects humans, birds, and other animals. It was first identified in the West Nile region of Uganda in 1937 and has since spread to many parts of the world, including North America, Europe, and Asia. The virus is primarily transmitted to humans through the bite of infected mosquitoes. WNV can cause a range of symptoms, from mild flu-like illness to severe neurologic diseases such as encephalitis and meningitis. While most infected individuals do not develop any symptoms, around 20% may experience fever, headache, body aches, nausea, vomiting, and rash. In rare cases, WNV can be fatal.

Market Dynamics:

The global West Nile virus market is driven by various factors. The rising incidence of WNV infections, especially in North America and Europe, is one of the primary drivers of market growth. Increasing awareness about the disease, its prevention, and diagnostics is also contributing to market expansion. For instance, according to data from the Centers for Disease Control and Prevention (CDC), the number of West Nile virus neuroinvasive disease cases reported to the national surveillance system increased from over 2000 cases in 2021 to over 2500 cases in 2022. States such as Texas, California, Louisiana, Nebraska, and Illinois witnessed the highest number of cases. The growing prevalence of the virus can be attributed to rising temperatures linked to climate change that are extending the transmission season and expanding the geographical range of mosquitoes that can spread the virus.

However, there are certain restraints hampering the growth of the market. The limited availability of effective treatments and vaccines is a major challenge in combating WNV. High costs associated with diagnosis and treatment further hinder market growth.

Despite these challenges, there are opportunities for market players to capitalize on. High growth potential in emerging economies, development of effective treatment options and rising usage of mosquito control methods presents a significant opportunity for growth. In addition, collaborations between pharmaceutical companies and research institutes can accelerate the development of innovative solutions for WNV.

Key features of the study:

This report provides in-depth analysis of the global West Nile virus market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global West Nile virus market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Sanofi, Pfizer, GlaxoSmithKline, Merck, AstraZeneca, Johnson & Johnson, F. Hoffmann-La Roche, Novartis, Cipla, and Gilead Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global West Nile virus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global West Nile virus market

Detailed Segmentation:

By Product Type:
- Antivirals
- Vaccines
- Antibiotics
- Analgesics
- Others (Immunoglobulins and among Others)
By Route of Administration:
- Oral
- Injectable
- Topical
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- Sanofi
- Pfizer
- GlaxoSmithKline
- Merck
- AstraZeneca
- Johnson & Johnson
- Hoffmann-La Roche
- Novartis
- Cipla
- Gilead Scienes

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global West Nile Virus Market, By Product Type
- Global West Nile Virus Market, By Route of Administration
- Global West Nile Virus Market, By Distribution Channel
- Global West Nile Virus Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
Epidemiology
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global West Nile Virus Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global West Nile Virus Market, By Product Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global West Nile Virus Market, By Route of Administration , 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Mn)

7. Global West Nile Virus Market, By Distribution Channel, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

8. Global West Nile Virus Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Germany
  - U.K.
  - France
  - Spain
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of APAC
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
Africa

9. Competitive Landscape

Sanofi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GlaxoSmithKline
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Merck
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
AstraZeneca
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Johnson & Johnson
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
F.Hoffmann-La Roche
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Novartis
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Cipla
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Gilead Sciences
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

西尼羅河病毒 (WNV) 市場按產品類型、給藥途徑、分銷管道和地區分類

West Nile Virus Market, By Product Type, By Route of Administration, By Distribution Channel, By Region

市場動態：

本研究的主要特點

目錄

第1章調查目的與前提條件

第2章市場展望

第3章市場動態、法規與趨勢分析

4. 全球西尼羅河病毒 (WNV) 市場-冠狀病毒 (COVID-19) 大流行的影響

5. 2020 年至 2032 年全球西尼羅河病毒 (WNV) 市場（依產品類型）

6. 2020 年至 2032 年按給藥途徑分類的全球西尼羅河病毒 (WNV) 市場

7. 2020 年至 2032 年全球西尼羅河病毒 (WNV) 市場按通路分類

8. 2020 年至 2032 年全球西尼羅河病毒 (WNV) 市場（按地區）

第9章競爭態勢

第 10 章章節

Market Dynamics:

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global West Nile Virus Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global West Nile Virus Market, By Product Type, 2020-2032, (US$ Mn)

6. Global West Nile Virus Market, By Route of Administration , 2020-2032, (US$ Mn)

7. Global West Nile Virus Market, By Distribution Channel, 2020-2032, (US$ Mn)

8. Global West Nile Virus Market, By Region, 2020-2032, (US$ Mn)

9. Competitive Landscape

10. Section

西尼羅河病毒 (WNV) 市場按產品類型、給藥途徑、分銷管道和地區分類

West Nile Virus Market, By Product Type, By Route of Administration, By Distribution Channel, By Region

市場動態：

本研究的主要特點

目錄

第1章 調查目的與前提條件

第2章 市場展望

第3章市場動態、法規與趨勢分析

4. 全球西尼羅河病毒 (WNV) 市場-冠狀病毒 (COVID-19) 大流行的影響

5. 2020 年至 2032 年全球西尼羅河病毒 (WNV) 市場（依產品類型）

6. 2020 年至 2032 年按給藥途徑分類的全球西尼羅河病毒 (WNV) 市場

7. 2020 年至 2032 年全球西尼羅河病毒 (WNV) 市場按通路分類

8. 2020 年至 2032 年全球西尼羅河病毒 (WNV) 市場（按地區）

第9章 競爭態勢

第 10 章 章節

Market Dynamics:

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global West Nile Virus Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global West Nile Virus Market, By Product Type, 2020-2032, (US$ Mn)

6. Global West Nile Virus Market, By Route of Administration , 2020-2032, (US$ Mn)

7. Global West Nile Virus Market, By Distribution Channel, 2020-2032, (US$ Mn)

8. Global West Nile Virus Market, By Region, 2020-2032, (US$ Mn)

9. Competitive Landscape

10. Section

第1章調查目的與前提條件

第2章市場展望

第9章競爭態勢

第 10 章章節